Literature DB >> 8133498

Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease.

S A Simpson1, M J Davidson, L H Barron.   

Abstract

The identification of an unstable trinucleotide repeat as the mutation responsible for Huntington's disease (HD) has given the hope that additional information can be provided about age of onset and mode of action of the mutated gene. We present in this paper results of a clinical and molecular study of 82 patients affected with HD from 46 pedigrees within the Grampian region, Scotland. Our results show a correlation between age of onset and size of the CAG expansion. This study has produced no overlap in mutation size between affected and unaffected alleles. The sex of the parent transmitting the mutated allele and the size of the normal allele have no significant effect on the clinical features of the disease. In the three juvenile cases the affected parent was the father but the number of cases is too small to produce statistical significance. An increase in the CAG repeat size is shown in the transmission of the gene in five cases, accompanied by an earlier age of onset in four; in three of these cases, the affected parent was the father. Eleven sib pairs were studied and there is a negative correlation between the difference in age at onset and the difference in repeat size. Thus there is some evidence of a relationship, but this is not statistically significant because of the small numbers involved. The presence of the same or different normal allele had no effect on age of onset in this small group. We suggest that additional factors, as yet unrecognised, influence the age of onset and clinical presentation of HD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133498      PMCID: PMC1016635          DOI: 10.1136/jmg.30.12.1014

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  8 in total

1.  One hundred requests for predictive testing for Huntington's disease.

Authors:  S A Simpson; J Besson; D Alexander; K Allan; A W Johnston
Journal:  Clin Genet       Date:  1992-06       Impact factor: 4.438

2.  The prevalence and patterns of care of Huntington's chorea in Grampian.

Authors:  S A Simpson; A W Johnston
Journal:  Br J Psychiatry       Date:  1989-12       Impact factor: 9.319

3.  Uptake of presymptomatic predictive testing for Huntington's disease.

Authors:  D Craufurd; A Dodge; L Kerzin-Storrar; R Harris
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

4.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

5.  Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

Authors:  A Tyler; D Ball; D Craufurd
Journal:  BMJ       Date:  1992-06-20

6.  A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes.

Authors:  J P Warner; L H Barron; D J Brock
Journal:  Mol Cell Probes       Date:  1993-06       Impact factor: 2.365

7.  The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD.

Authors:  L A Farrer; L A Cupples; P Wiater; P M Conneally; J F Gusella; R H Myers
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

8.  The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy.

Authors:  A Hunter; C Tsilfidis; G Mettler; P Jacob; M Mahadevan; L Surh; R Korneluk
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

  8 in total
  7 in total

Review 1.  Huntington disease--another chapter rewritten.

Authors:  M A Nance
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  A comparison of the Huntington's disease associated trinucleotide repeat between Chinese and white populations.

Authors:  B W Soong; J T Wang
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

3.  Trinucleotide repeat length and progression of illness in Huntington's disease.

Authors:  K Kieburtz; M MacDonald; C Shih; A Feigin; K Steinberg; K Bordwell; C Zimmerman; J Srinidhi; J Sotack; J Gusella
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

Review 4.  A specific mutation for Huntington's disease.

Authors:  P S Harper
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

5.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

6.  Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease.

Authors:  M F Ghilardi; G Silvestri; A Feigin; P Mattis; D Zgaljardic; C Moisello; D Crupi; L Marinelli; A Dirocco; D Eidelberg
Journal:  Parkinsonism Relat Disord       Date:  2008-03-03       Impact factor: 4.891

7.  The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis.

Authors:  Oliver Quarrell; Kirsty L O'Donovan; Oliver Bandmann; Mark Strong
Journal:  PLoS Curr       Date:  2012-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.